Also written by Tomi Kilgore:
Share Buybacks Will Return with a Vengeance Next Year
x hide permanently

KaloBios terminates Martin Shkreli as CEO

MarketWatch

KaloBios Pharmaceuticals Inc. said Martin Shkreli was terminated as its chief executive office on Dec. 17. Shkreli has also resigned as a member of the board of directors. Shkreli was arrested last week by the Federal Bureau of Investigations and accused of securities and wire fraud based on his former work as a manager at hedge fund MSMB Capital Management and CEO of Retrophin Inc. . Shkreli ...

Mentions: Management Hedge Fund CEO